Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

infectious diseases

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

- PMLiVE

Call for closer ties between pharma and animal health

One Health conference hears how joint workingcould benefit both sectors

- PMLiVE

FDA backs Cubist’s antibiotic Zerbaxa

Combination cephalosporin and beta lactamase inhibitor wins US approval

The impending threat of antibiotic resistance

Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

Xellia forms scientific advisory board

Will further progress on innovative anti-infectives

Can Cinderella save us?

Antibiotic resistance to lead to millions of deaths

UK publishes first progress report for antimicrobial resistance strategy

- PMLiVE

UPDATE: Merck to acquire Cubist for $8.4bn

Will expand company's presence in antibiotics

Can Cinderella save us?

NICE wants responsible use of antibiotics in pneumonia

Drugs often prescribed to wrong patients

EU flag

EU consortium focuses on antibiotic ‘husbandry’

IMI-backed group to research ways to tackle antimicrobial resistance

- PMLiVE

Charity forms to tackle resistance to antibiotics

Antibiotic Research UK hopes to develop new drug in dive years

National Institute for Health and Care Excellence NICE logo

NICE working to tackle antimicrobial resistance

Two guidelines in development to improve NHS use of antibiotic drugs

- PMLiVE

Cubist launches Zurich base

US antibiotic company expands into Europe

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links